GlassScriptPhysician profile
Christine Heath
NPI 1629007273
$1,472.02
in general payments reported to CMS, 2019-2025
13 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.02 · 2022: $215 · 2023: $631 · 2024: $453 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $934.69 | 2022-2025 | |
| Kerecis Limited | $144.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Novartis Pharmaceuticals Corporation | $120.50 | 2023-2025 | |
| Pfizer INC. | $53.35 | 2023-2024 | |
| Livanova USA, INC. | $47.24 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Biogen, INC. | $33.17 | 2021 | |
| Argenx US, INC. | $27.95 | 2023 | Vyvgart Hytrulo |
| Lundbeck LLC | $21.93 | 2024 | Vyepti |
| Impel Pharmaceuticals INC. | $20.00 | 2023 | Trudhesa |
| Medtronic, INC. | $18.36 | 2022 | |
| Tg Therapeutics, INC. | $18.30 | 2024 | |
| Allergan, INC. | $16.85 | 2021 | |
| Emd Serono, INC. | $14.86 | 2023 | Mavenclad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Heath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.